Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma-Reference-Cited by-同舟云学术

Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of Engraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

Published:2013-09 Issue:9 Volume:19 Page:1368-1373
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Cornell Robert Frank,Hari Parameswaran,Zhang Mei-Jie,Zhong Xiabao,Thompson Jonathan,Fenske Timothy S.,Horowitz Mary M.,Komorowski Richard,Palmer Jeanne,Pasquini Marcelo C.,Rizzo J. Douglas,Saber Wael,Thomas Mathew,Drobyski William R.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation;Cavo;Blood,2011

2. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative;Gertz;Mayo Clin Proc,2008

3. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: Update of the 2001 evidence-based review;Oliamsky;Biol Blood Marrow Transplant,2011

4. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center;Carreras;Bone Marrow Transplant,2010

5. Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation;Foncillas;J Pediatr Hematol Oncol,2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and Outcomes;Annals of Transplantation;2024-06-06

2. Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantation;Blood Science;2024-05-16

3. Characteristics of Engraftment Syndrome following Autologous Stem Cell Transplantation in Light Chain Amyloidosis with Renal Involvement;Transplantation and Cellular Therapy;2023-02

4. Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management;Medical Oncology;2022-12-02

5. A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation;Transplantation and Cellular Therapy;2022-12